| Chemical | Toxicity Endpoint Type | Endpoint Description | Endpoint Value | Sample Size | Life Cycle Stage | Study Duration | Type |
|---|---|---|---|---|---|---|---|
| IRON (elemental), LEAD (elemental) | TOX-Non-Repro-Sublethal - cellular/biochemical effects | serum glutamic pyruvic transaminase activity vs controls | increased @ 8 #four iron shot | 8/group | Adult | 14 d | Toxicity Factor Datasets |
| IRON (elemental), LEAD (elemental) | TOX-Non-Repro-Sublethal - organ/system effects | incidence of hemosiderosis in liver vs controls | increased with all treatments | 8/group | Adult | 14 d | Toxicity Factor Datasets |
| IRON (elemental), LEAD (elemental) | TOX-Non-Repro-Sublethal - organ/system effects | incidence of inclusion bodies in kidney vs controls | increased @ 8 #four iron shot | 8/group | Adult | 14 d | Toxicity Factor Datasets |
| IRON (elemental), LEAD (elemental) | TOX-Non-Repro-Sublethal - cellular/biochemical effects | serum enzyme levels versus controls (at 30 or 60 d post dose) | no effect | 2/group | Adult | 2 mos | Toxicity Factor Datasets |
